Safety and Efficacy of Facial Cleanser

The Safety and Efficacy of Facial Cleanser Containing Combination of Olive Oil, Virgin Coconut Oil, Butylene Glycol and Hyaluronic Acid on Skin Hydration and Skin Elasticity

This study is conducted to evaluate the safety and effectiveness of facial cleanser X containing combination of olive oil, virgin coconut oil, butylene glycol and hyaluronic acid on skin hydration and skin elasticity. The study duration is 5 weeks and the skin assessment will be carried out at baseline, week 3 and week 5.The main questions this study aims to answer are:

  1. The effect of product on skin hydration.
  2. The effect of product on skin elasticity.
  3. To observe any adverse effect occurrence with the usage of the product.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Selangor
      • Petaling Jaya, Selangor, Malaysia, 47810
        • Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 55 years (Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Malaysia citizen
  • Male and female (age 35-55 years old)

Exclusion Criteria:

  • Participants who have acne which require medical treatment.
  • Participants taking isotretinoin
  • Participants who had undergo any cosmetic procedures such as laser & light treatment, botulinum toxin A injections and chemical peeling for the past 3 months
  • Participants who are immunocompromised
  • Participants with history of facial surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Product X facial cleanser
Participants will used Product X facial cleanser twice daily for 5 weeks
Product X facial cleanser contain olive oil, virgin coconut oil, butylene glycol and hyaluronic acid

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in skin hydration from baseline and at week 3 and 5 after using facial cleanser X
Time Frame: Baseline, week 3 and week 5
Skin hydration will be assessed using JANUS III skin analyzer
Baseline, week 3 and week 5
Change in skin elasticity from baseline and at week 3 and 5 after using facial cleanser X
Time Frame: Baseline, week 3 and week 5
Skin elasticity will be assessed using JANUS III skin analyzer
Baseline, week 3 and week 5
Adverse effect after using facial cleanser X
Time Frame: Week 5
Based on adverse effect occurrence on participants that occur during study period (5 weeks)
Week 5

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

September 30, 2023

Study Registration Dates

First Submitted

January 10, 2023

First Submitted That Met QC Criteria

January 10, 2023

First Posted (Actual)

January 20, 2023

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 27, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • UMRAMREC004-22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Other: Product X facial cleanser

Subscribe